Genenta Historical Balance Sheet

GNTA Stock

USD 3.71 0.19 4.87%

Trend analysis of Genenta Science SpA balance sheet accounts such as Total Current Liabilities of 1.6 M or Total Stockholder Equity of 27.4 M provides information on Genenta Science's total assets, liabilities, and equity, which is the actual value of Genenta Science SpA to its prevalent stockholders. By breaking down trends over time using Genenta Science balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Genenta Science SpA latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Genenta Science SpA is a good buy for the upcoming year.

Genenta Science Inventory

2.18

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Genenta Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Genenta Science SpA at a specified time, usually calculated after every quarter, six months, or one year. Genenta Science Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Genenta Science and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Genenta currently owns. An asset can also be divided into two categories, current and non-current.

Genenta Science Balance Sheet Chart

At present, Genenta Science's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.6 M, whereas Other Current Liabilities is forecasted to decline to about 1.1 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Cash And Short Term Investments

Total Assets

Total assets refers to the total amount of Genenta Science assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Genenta Science SpA books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Genenta Science balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Genenta Science SpA are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Genenta Science SpA balance sheet. This account contains Genenta Science investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Genenta Science SpA fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Genenta Science's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Genenta Science SpA current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	989.5K	1.4M	1.3M	1.1M
Total Assets	33.4M	22.3M	25.7M	29.6M

Other Current Liab Total Assets

Genenta Science balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock
Total Assets		-0.89	-0.77	1.0	0.74	-0.57	-0.41	-0.49	0.01	0.38	0.77	0.8	-0.26	0.99	0.87	0.26	0.38	0.71	0.51	-0.77	-0.78	1.0	1.0	0.73	1.0	0.73
Other Current Liab	-0.89		0.87	-0.89	-0.94	0.87	0.03	0.81	-0.02	-0.01	-0.95	-0.95	0.35	-0.8	-0.98	-0.49	-0.71	-0.91	-0.82	0.95	0.85	-0.89	-0.87	-0.92	-0.88	-0.92
Total Current Liabilities	-0.77	0.87		-0.78	-0.9	0.84	-0.15	0.79	0.46	0.17	-0.7	-0.69	0.74	-0.68	-0.78	-0.58	-0.7	-0.74	-0.81	0.89	0.99	-0.78	-0.76	-0.87	-0.78	-0.87
Total Stockholder Equity	1.0	-0.89	-0.78		0.74	-0.58	-0.4	-0.49	-0.02	0.38	0.77	0.8	-0.28	0.98	0.87	0.26	0.38	0.71	0.52	-0.78	-0.8	1.0	1.0	0.74	1.0	0.74
Other Liab	0.74	-0.94	-0.9	0.74		-0.91	0.28	-0.94	-0.11	-0.3	0.88	0.86	-0.53	0.62	0.87	0.66	0.89	0.83	0.92	-0.99	-0.86	0.74	0.72	0.96	0.73	0.96
Net Tangible Assets	-0.57	0.87	0.84	-0.58	-0.91		-0.37	0.9	0.12	0.39	-0.85	-0.82	0.46	-0.44	-0.84	-0.67	-0.84	-0.89	-0.92	0.87	0.81	-0.58	-0.55	-0.85	-0.56	-0.85
Net Debt	-0.41	0.03	-0.15	-0.4	0.28	-0.37		-0.54	-0.24	-1.0	-0.01	-0.09	-0.49	-0.52	-0.15	0.61	0.66	-0.02	0.41	-0.21	-0.09	-0.4	-0.42	0.18	-0.41	0.18
Retained Earnings	-0.49	0.81	0.79	-0.49	-0.94	0.9	-0.54		0.1	0.55	-0.79	-0.74	0.53	-0.34	-0.73	-0.67	-0.97	-0.76	-0.94	0.92	0.72	-0.49	-0.46	-0.9	-0.48	-0.9
Accounts Payable	0.01	-0.02	0.46	-0.02	-0.11	0.12	-0.24	0.1		0.24	0.28	0.3	0.84	0.02	0.14	-0.2	-0.06	0.12	-0.17	0.1	0.49	-0.02	-0.01	-0.14	-0.04	-0.14
Cash	0.38	-0.01	0.17	0.38	-0.3	0.39	-1.0	0.55	0.24		-0.01	0.07	0.5	0.5	0.13	-0.64	-0.67	0.01	-0.42	0.23	0.11	0.38	0.4	-0.2	0.39	-0.2
Non Current Assets Total	0.77	-0.95	-0.7	0.77	0.88	-0.85	-0.01	-0.79	0.28	-0.01		0.99	-0.09	0.67	0.97	0.45	0.71	0.95	0.82	-0.89	-0.66	0.77	0.75	0.88	0.75	0.88
Non Currrent Assets Other	0.8	-0.95	-0.69	0.8	0.86	-0.82	-0.09	-0.74	0.3	0.07	0.99		-0.05	0.72	0.98	0.4	0.65	0.94	0.77	-0.86	-0.65	0.8	0.78	0.84	0.78	0.84
Other Assets	-0.26	0.35	0.74	-0.28	-0.53	0.46	-0.49	0.53	0.84	0.5	-0.09	-0.05		-0.21	-0.17	-0.57	-0.53	-0.14	-0.47	0.5	0.74	-0.28	-0.27	-0.47	-0.29	-0.47
Cash And Short Term Investments	0.99	-0.8	-0.68	0.98	0.62	-0.44	-0.52	-0.34	0.02	0.5	0.67	0.72	-0.21		0.79	0.16	0.24	0.6	0.36	-0.66	-0.71	0.98	0.99	0.62	0.99	0.62
Net Receivables	0.87	-0.98	-0.78	0.87	0.87	-0.84	-0.15	-0.73	0.14	0.13	0.97	0.98	-0.17	0.79		0.37	0.61	0.96	0.77	-0.88	-0.76	0.87	0.85	0.86	0.86	0.86
Common Stock Shares Outstanding	0.26	-0.49	-0.58	0.26	0.66	-0.67	0.61	-0.67	-0.2	-0.64	0.45	0.4	-0.57	0.16	0.37		0.79	0.34	0.65	-0.59	-0.55	0.26	0.25	0.57	0.25	0.57
Non Current Liabilities Total	0.38	-0.71	-0.7	0.38	0.89	-0.84	0.66	-0.97	-0.06	-0.67	0.71	0.65	-0.53	0.24	0.61	0.79		0.62	0.88	-0.86	-0.63	0.38	0.36	0.82	0.37	0.82
Inventory	0.71	-0.91	-0.74	0.71	0.83	-0.89	-0.02	-0.76	0.12	0.01	0.95	0.94	-0.14	0.6	0.96	0.34	0.62		0.83	-0.83	-0.7	0.71	0.69	0.84	0.7	0.84
Other Current Assets	0.51	-0.82	-0.81	0.52	0.92	-0.92	0.41	-0.94	-0.17	-0.42	0.82	0.77	-0.47	0.36	0.77	0.65	0.88	0.83		-0.91	-0.74	0.52	0.49	0.95	0.51	0.95
Other Stockholder Equity	-0.77	0.95	0.89	-0.78	-0.99	0.87	-0.21	0.92	0.1	0.23	-0.89	-0.86	0.5	-0.66	-0.88	-0.59	-0.86	-0.83	-0.91		0.85	-0.78	-0.76	-0.98	-0.77	-0.98
Total Liab	-0.78	0.85	0.99	-0.8	-0.86	0.81	-0.09	0.72	0.49	0.11	-0.66	-0.65	0.74	-0.71	-0.76	-0.55	-0.63	-0.7	-0.74	0.85		-0.8	-0.78	-0.82	-0.8	-0.82
Net Invested Capital	1.0	-0.89	-0.78	1.0	0.74	-0.58	-0.4	-0.49	-0.02	0.38	0.77	0.8	-0.28	0.98	0.87	0.26	0.38	0.71	0.52	-0.78	-0.8		1.0	0.74	1.0	0.74
Total Current Assets	1.0	-0.87	-0.76	1.0	0.72	-0.55	-0.42	-0.46	-0.01	0.4	0.75	0.78	-0.27	0.99	0.85	0.25	0.36	0.69	0.49	-0.76	-0.78	1.0		0.72	1.0	0.72
Capital Stock	0.73	-0.92	-0.87	0.74	0.96	-0.85	0.18	-0.9	-0.14	-0.2	0.88	0.84	-0.47	0.62	0.86	0.57	0.82	0.84	0.95	-0.98	-0.82	0.74	0.72		0.73	1.0
Net Working Capital	1.0	-0.88	-0.78	1.0	0.73	-0.56	-0.41	-0.48	-0.04	0.39	0.75	0.78	-0.29	0.99	0.86	0.25	0.37	0.7	0.51	-0.77	-0.8	1.0	1.0	0.73		0.73
Common Stock	0.73	-0.92	-0.87	0.74	0.96	-0.85	0.18	-0.9	-0.14	-0.2	0.88	0.84	-0.47	0.62	0.86	0.57	0.82	0.84	0.95	-0.98	-0.82	0.74	0.72	1.0	0.73

Click cells to compare fundamentals

Genenta Science Account Relationship Matchups

Genenta Science balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	17.5M	40.0M	33.4M	22.3M	25.7M	29.6M
Other Current Liab	1.8M	945.2K	989.5K	1.4M	1.3M	1.1M
Total Current Liabilities	2.3M	1.1M	2.2M	1.7M	1.6M	1.6M
Total Stockholder Equity	15.2M	38.9M	31.1M	20.4M	23.5M	27.4M
Property Plant And Equipment Net	19.0K	23.1K	111.6K	57.0K	65.6K	46.4K
Net Debt	(15.5M)	(37.2M)	(29.8M)	(3.7M)	(4.2M)	(4.5M)
Retained Earnings	(21.5M)	(27.0M)	(35.5M)	(47.1M)	(42.4M)	(44.6M)
Accounts Payable	555.0K	189.9K	1.2M	295.0K	339.2K	617.4K
Cash	15.5M	37.2M	29.8M	3.7M	3.3M	3.2M
Non Current Assets Total	967.9K	1.3M	1.7M	1.1M	1.3M	1.3M
Non Currrent Assets Other	949.0K	1.2M	1.6M	980.7K	1.1M	1.2M
Other Assets	949.0K	0.0	1.6M	(899.0)	(809.1)	(768.64)
Cash And Short Term Investments	15.5M	37.2M	29.8M	18.8M	21.6M	26.7M
Net Receivables	760.6K	1.4M	1.6M	833.7K	958.7K	1.1M
Liabilities And Stockholders Equity	17.5M	40.0M	33.4M	22.3M	25.7M	29.6M
Non Current Liabilities Total	17.4K	30.6K	116.2K	179.2K	206.1K	216.4K
Inventory	27.7K	76.3K	144.7K	2.0	2.3	2.18
Other Current Assets	1.1M	1.5M	1.9M	2.5M	2.9M	1.6M
Total Liab	2.4M	1.2M	2.3M	1.9M	1.7M	1.6M
Net Invested Capital	15.2M	38.9M	31.1M	20.4M	23.5M	27.4M
Total Current Assets	16.5M	38.8M	31.7M	21.3M	24.4M	28.4M
Capital Stock	37.1K	65.9M	66.6M	67.3M	77.4M	44.0M
Net Working Capital	14.2M	37.6M	29.5M	19.5M	22.4M	26.2M
Common Stock	37.1K	65.9M	66.6M	67.3M	77.4M	44.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether Genenta Science SpA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genenta Science's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genenta Science Spa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genenta Science Spa Stock:

How To Invest In Genenta

Details

Is Genenta Stock a good investment?

Details

What is Genenta Science's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genenta Science. If investors know Genenta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genenta Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.51)

Return On Assets

(0.26)

Return On Equity

(0.43)

The market value of Genenta Science SpA is measured differently than its book value, which is the value of Genenta that is recorded on the company's balance sheet. Investors also form their own opinion of Genenta Science's value that differs from its market value or its book value, called intrinsic value, which is Genenta Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genenta Science's market value can be influenced by many factors that don't directly affect Genenta Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genenta Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genenta Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genenta Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genenta Historical Balance Sheet

Genenta Science Inventory

2.18

About Genenta Balance Sheet Analysis

Genenta Science Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Cash And Short Term Investments

Genenta Science balance sheet Correlations

Genenta Science Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genenta Science balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Other Liab
Common Stock	- 0.98	Other Stockholder Equity
Capital Stock	- 0.98	Other Stockholder Equity
Net Receivables	- 0.98	Other Current Liab
Non Current Liabilities Total	- 0.97	Retained Earnings